What are CSF1R inhibitor drugs?

CSF1R inhibitor drugs are pharmacologic agents that share a common mechanism (typically targeting CSF1R (Colony-Stimulating Factor 1 Receptor)). 0 are currently marketed, with 3 more in clinical development.

CSF1R inhibitor

0 marketed 3 in Phase 3

This page covers all CSF1R inhibitor drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting CSF1R (Colony-Stimulating Factor 1 Receptor).

Targets

CSF1R (Colony-Stimulating Factor 1 Receptor)

Phase 3 pipeline (3)

CCI18781 · GlaxoSmithKline · Oncology
CCI18781 is a selective inhibitor of colony-stimulating factor 1 receptor (CSF1R) that reduces macrophage proliferation and activation in the tumor microenvironment.
IMP4927 · Impact Therapeutics, Inc. · Oncology
IMP4927 is a selective inhibitor of colony-stimulating factor 1 receptor (CSF1R) that reduces macrophage infiltration and activation in the tumor microenvironment.
ABBV-706 · AbbVie · Oncology
ABBV-706 is a selective inhibitor of colony-stimulating factor 1 receptor (CSF1R) that reduces macrophage proliferation and activation in the tumor microenvironment.